SynthesisJournal of the National Cancer Institute2019

Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis.

Quisette P Janssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.